Publications

Identification of p38 MAPK inhibition as a neuroprotective strategy for combinatorial SMA therapy

 70
Identification of p38 MAPK inhibition as a neuroprotective strategy for combinatorial SMA therapy

Tags:

Previous Article

ERK1/2 signaling targeting in cancer

Next Article

MAPK inhibition to protect against spinal muscular atrophy

Related Posts

Bright-light treatment ameliorates motor and non- motor deficits through distinct visual circuits in a mouse model of Parkinson’s disease

Bright-light treatment ameliorates motor and non- motor...

 63

Neuronal inflammasomes: balancing immunity, neuroinflammation, and homeostasis

Neuronal inflammasomes: balancing immunity, neuroinflam...

 78

Cellular deconstruction of the human skeletal muscle microenvironment identifies an exercise- induced histaminergic crosstalk

Cellular deconstruction of the human skeletal muscle m...

 156